Stereoselective Inhibition of CYP2C19 and CYP3A4 by Fluoxetine and Its Metabolite: Implications for Risk Assessment of Multiple Time-Dependent Inhibitor Systems
Drug Metabolism and Disposition - United States
doi 10.1124/dmd.113.052639
Full Text
Open PDFAbstract
Available in full text
Date
June 19, 2013
Authors
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)